7.495
price up icon0.74%   0.055
after-market Handel nachbörslich: 7.46 -0.035 -0.47%
loading
Schlusskurs vom Vortag:
$7.44
Offen:
$7.5
24-Stunden-Volumen:
192.52K
Relative Volume:
0.77
Marktkapitalisierung:
$276.02M
Einnahmen:
$128.45M
Nettoeinkommen (Verlust:
$6.54M
KGV:
-2.2575
EPS:
-3.32
Netto-Cashflow:
$-8.79M
1W Leistung:
+0.20%
1M Leistung:
+36.40%
6M Leistung:
+33.36%
1J Leistung:
+2.95%
1-Tages-Spanne:
Value
$7.46
$7.74
1-Wochen-Bereich:
Value
$6.83
$7.99
52-Wochen-Spanne:
Value
$3.6793
$8.90

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Name
Firmenname
Lifecore Biomedical Inc
Name
Telefon
(952) 368-4300
Name
Adresse
3515 LYMAN BOULEVARD, CHASKA
Name
Mitarbeiter
524
Name
Twitter
Name
Nächster Verdiensttermin
2024-08-29
Name
Neueste SEC-Einreichungen
Name
LFCR's Discussions on Twitter

Vergleichen Sie LFCR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
LFCR
Lifecore Biomedical Inc
7.495 276.02M 128.45M 6.54M -8.79M -3.32
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
176.74 79.74B 9.15B 2.43B 2.31B 4.92
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.72 43.95B 14.26B 1.55B 0 0.3327
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.57 43.02B 30.27B 1.93B 3.45B 0.444
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.57 18.77B 16.77B -959.00M 1.37B -2.00
Drug Manufacturers - Specialty & Generic icon
VTRS
Viatris Inc
13.22 15.78B 15.05B -883.30M 1.89B 1.53

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-09-05 Eingeleitet Craig Hallum Buy
2024-08-28 Herabstufung Barrington Research Outperform → Mkt Perform
2023-03-20 Herabstufung Stephens Overweight → Equal-Weight

Lifecore Biomedical Inc Aktie (LFCR) Neueste Nachrichten

pulisher
Nov 27, 2024

Lifecore extends credit terms, simplifies interest rates By Investing.com - Investing.com Canada

Nov 27, 2024
pulisher
Nov 26, 2024

Lifecore extends credit terms, simplifies interest rates - Investing.com India

Nov 26, 2024
pulisher
Nov 26, 2024

Lifecore Biomedical Strengthens Financial Position with Key Moves - TipRanks

Nov 26, 2024
pulisher
Nov 26, 2024

Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO - GlobeNewswire

Nov 26, 2024
pulisher
Nov 26, 2024

Lifecore Biomedical Extends Credit Facility to 2027, Secures $24.3M Financing | LFCR Stock News - StockTitan

Nov 26, 2024
pulisher
Nov 26, 2024

Lifecore Biomedical, Inc. (NASDAQ:LFCR) Soars 36% But It's A Story Of Risk Vs Reward - Simply Wall St

Nov 26, 2024
pulisher
Nov 25, 2024

Lifecore Biomedical (NASDAQ:LFCR) Price Target Raised to $10.00 - Defense World

Nov 25, 2024
pulisher
Nov 23, 2024

Lifecore Biomedical (NASDAQ:LFCR) Price Target Raised to $10.00 at Craig Hallum - MarketBeat

Nov 23, 2024
pulisher
Nov 22, 2024

Lifecore Biomedical shares target upgraded, keeps buy on growth prospects By Investing.com - Investing.com UK

Nov 22, 2024
pulisher
Nov 21, 2024

Earnings call: Lifecore Biomedical Q1 fiscal 2025 shows steady growth - Investing.com

Nov 21, 2024
pulisher
Nov 21, 2024

Lifecore Biomedical Hosts Virtual Investor Day - The Manila Times

Nov 21, 2024
pulisher
Nov 21, 2024

Earnings call: Lifecore Biomedical Q1 Fiscal 2025 highlights growth strategy - Investing.com

Nov 21, 2024
pulisher
Nov 21, 2024

Earnings call: Lifecore Biomedical Q1 Fiscal 2025 highlights growth strategy By Investing.com - Investing.com Canada

Nov 21, 2024
pulisher
Nov 21, 2024

Lifecore Biomedical Plans Strategic Growth and Transformation - TipRanks

Nov 21, 2024
pulisher
Nov 20, 2024

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates C - GuruFocus.com

Nov 20, 2024
pulisher
Nov 19, 2024

Trend Tracker for (LFCR) - Stock Traders Daily

Nov 19, 2024
pulisher
Nov 15, 2024

Here’s Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR) - Insider Monkey

Nov 15, 2024
pulisher
Nov 13, 2024

Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) biggest owners are individual investors who got richer after stock soared 14% last week - Simply Wall St

Nov 13, 2024
pulisher
Nov 12, 2024

Lifecore Biomedical to Present at Stephens Annual Investment Conference - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) top owners are retail investors with 35% stake, while 35% is held by hedge funds - Yahoo Finance

Nov 12, 2024
pulisher
Nov 12, 2024

Lifecore Biomedical: Finally A 'Pure Play' CDMO Business - Seeking Alpha

Nov 12, 2024
pulisher
Nov 07, 2024

Lifecore to host virtual investor day on November 21 - Nasdaq

Nov 07, 2024
pulisher
Nov 07, 2024

Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024 - The Manila Times

Nov 07, 2024
pulisher
Nov 07, 2024

Lifecore Biomedical (LFCR) to Host Virtual Investor Day: Growth Strategy Unveiling | LFCR Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

Lifecore Biomedical (NASDAQ:LFCR) Trading Up 4.5%Time to Buy? - MarketBeat

Nov 07, 2024
pulisher
Nov 04, 2024

Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

Lifecore Biomedical Makes Leadership Appointments - Contract Pharma

Nov 04, 2024
pulisher
Nov 01, 2024

Chaska’s Lifecore looks to growth in coming years after emerging from delisting challenge - Star Tribune

Nov 01, 2024
pulisher
Oct 28, 2024

How To Trade (LFCR) - Stock Traders Daily

Oct 28, 2024
pulisher
Oct 17, 2024

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer - Benzinga

Oct 17, 2024
pulisher
Oct 16, 2024

Hyaluronic Acid (HA) Raw Material Market Size And Forecast -Salix Pharmaceuticals, ALLERGAN, Lifecore Biomedical, LLC, S – IndiaPolitics.com - IndiaPolitics.com

Oct 16, 2024
pulisher
Oct 11, 2024

Johnson Fistel LLP Investigates Lifecore Biomedical, Inc’s - GlobeNewswire

Oct 11, 2024
pulisher
Oct 09, 2024

Q3 2025 Earnings Forecast for Lifecore Biomedical, Inc. Issued By Barrington Research (NASDAQ:LFCR) - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

Brokers Set Expectations for Lifecore Biomedical, Inc.'s Q1 2026 Earnings (NASDAQ:LFCR) - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

Wynnefield entities buy $1.2m of Lifecore Biomedical stock By Investing.com - Investing.com South Africa

Oct 08, 2024
pulisher
Oct 07, 2024

Legion Partners Asset Management, LLC Increases Stake in Lifecore Biomedical Inc - GuruFocus.com

Oct 07, 2024
pulisher
Oct 07, 2024

Wynnefield Partners Small Cap Acquires 122,930 Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR) Stock - MarketBeat

Oct 07, 2024
pulisher
Oct 07, 2024

Wynnefield entities buy $1.2m of Lifecore Biomedical stock - Investing.com

Oct 07, 2024
pulisher
Oct 07, 2024

Lifecore Biomedical stock price target increased on growth prospects By Investing.com - Investing.com UK

Oct 07, 2024
pulisher
Oct 07, 2024

Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q1 2025 Earnings Call Transcript - Insider Monkey

Oct 07, 2024
pulisher
Oct 07, 2024

Earnings call: Lifecore Biomedical reports fiscal Q1 2025 results By Investing.com - Investing.com Australia

Oct 07, 2024
pulisher
Oct 07, 2024

Earnings call: Lifecore Biomedical reports fiscal Q1 2025 results - Investing.com India

Oct 07, 2024
pulisher
Oct 07, 2024

Lifecore Biomedical Inc (LFCR) Q1 2025 Earnings Call Transcript Highlights: Navigating ... By GuruFocus - Investing.com Canada

Oct 07, 2024
pulisher
Oct 06, 2024

Q1 2025 Lifecore Biomedical Inc Earnings Call Transcript - Stockxpo

Oct 06, 2024
pulisher
Oct 06, 2024

Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Purchased by Marshall Wace LLP - MarketBeat

Oct 06, 2024
pulisher
Oct 05, 2024

exhibit991-lfcrq1fy25ear.htm - SEC.gov

Oct 05, 2024
pulisher
Oct 05, 2024

Lifecore Biomedical: Fiscal Q1 Earnings Snapshot - mySA

Oct 05, 2024
pulisher
Oct 04, 2024

Lifecore Biomedical completes $24.3M private stock sale - Investing.com

Oct 04, 2024

Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$90.27
price up icon 0.83%
$13.13
price up icon 0.00%
$86.59
price up icon 0.19%
$61.00
price up icon 0.41%
$126.59
price down icon 1.03%
$13.22
price up icon 1.07%
Kapitalisierung:     |  Volumen (24h):